Plain-English translation of NCT06200311 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether a minimally invasive heart procedure called pulmonary vein isolation is better than medication alone for treating atrial fibrillation in people whose heart muscle has been weakened by the irregular heartbeat. Atrial fibrillation is a condition where the upper chambers of the heart beat irregularly, and over time this can damage the heart muscle itself. The study wants to see which approach โ the procedure or medication โ better prevents serious heart problems and hospitalizations.
When atrial fibrillation goes untreated for a long time, it can permanently damage and weaken the heart muscle, making the irregular heartbeat harder to control. Doctors want to know whether treating it with a procedure early on can prevent this damage and lead to better outcomes than managing it with medication alone.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this trial, you will be randomly assigned to either receive the heart procedure or start on medication. You'll be followed for about 2.5 years through visits at one of 13 Dutch hospitals, with some monitoring done remotely using a mobile health app on your phone. Your heart rhythm will be checked regularly, you'll answer questionnaires about your symptoms and quality of life, and your doctors will track whether you have any serious heart events or hospitalizations.
AI-generated summary from trial data ยท Jun 2, 2026 ยท Not medical advice
Netherlands